Syngene International Intrinsic Value

Syngene International intrinsic value. Syngene International (SYNGENE) median intrinsic value is ₹131.21 from 9 valuation models (range ₹131–₹276), vs current price ₹437.35 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Browse Syngene International annual reports for revenue, profit, balance sheet and cash flow data.

Market Price (CMP)
₹437.35
Primary Intrinsic Value
₹131.21
Market Cap
₹176.3K Cr
-70.0% Downside
Median Value
₹131.21
Value Range
₹131 - ₹276
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

SYNGENE Valuation Methods Summary — DCF, Graham Number & P/E

Syngene International intrinsic value across 9 models vs current price ₹437.35 — upside/downside and value range per method. Analyse SYNGENE shareholding pattern to track promoter, FII and institutional holdings.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹131.21 ₹104.97 - ₹157.45 -70.0% EPS: ₹3.20, Sector P/E: 22x
Book Value Method asset ₹240.15 ₹216.14 - ₹264.17 -45.1% Book Value/Share: ₹120.07, P/B: 2.0x
Revenue Multiple Method revenue ₹170.92 ₹153.83 - ₹188.01 -60.9% Revenue/Share: ₹85.46, P/S: 2.0x
EBITDA Multiple Method earnings ₹174.94 ₹157.45 - ₹192.43 -60.0% EBITDA: ₹676.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹275.95 ₹220.76 - ₹331.14 -36.9% CF Growth: 12.0%, Discount: 15%
PEG Ratio Method growth ₹131.21 ₹118.09 - ₹144.33 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹131.21 ₹118.09 - ₹144.33 -70.0% Revenue Growth: 6.0%, Adj P/E: 15.5x
Graham Defensive Method conservative ₹131.21 ₹118.09 - ₹144.33 -70.0% EPS: ₹3.20, BVPS: ₹120.07
Dividend Yield Method dividend ₹131.21 ₹118.09 - ₹144.33 -70.0% DPS: ₹1.25, Target Yield: 2.5%
Method Types: Earnings Asset DCF Growth Dividend Conservative

SYNGENE Intrinsic Value vs Market Price — All Valuation Models

Syngene International fair value range ₹131–₹276 vs current market price ₹437.35 across 9 valuation models. For current market price and key ratios, visit SYNGENE share price.

SYNGENE Intrinsic Value Analysis — Undervalued or Overvalued?

Syngene International median intrinsic value ₹131.21, current price ₹437.35 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.

What is the intrinsic value of SYNGENE?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Syngene International (SYNGENE) is ₹131.21 (median value). With the current market price of ₹437.35, this represents a -70.0% variance from our estimated fair value.

The valuation range spans from ₹131.21 to ₹275.95, indicating ₹131.21 - ₹275.95.

Is SYNGENE undervalued or overvalued?

Based on our multi-method analysis, Syngene International (SYNGENE) appears to be trading above calculated value by approximately 70.0%.

SYNGENE Financial Health — Key Ratios vs Industry Benchmarks

Syngene International financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity 2.6% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin 17.0% Industry Standard: 20%+ Above 10% Indicates operational efficiency level
Asset Turnover Ratio 0.49x Industry Standard: 1.0x+ Below 0.5x Measures asset utilization efficiency

SYNGENE Cash Flow Quality — Operating & Free Cash Flow

Syngene International operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹915 Cr ₹496 Cr Positive Free Cash Flow 8/10
March 2025 ₹1,168 Cr ₹796 Cr Positive Free Cash Flow 8/10
March 2024 ₹1,042 Cr ₹795 Cr Positive Free Cash Flow 8/10
March 2023 ₹824 Cr ₹498 Cr Positive Free Cash Flow 8/10
March 2022 ₹581 Cr ₹276 Cr Positive Free Cash Flow 7/10